对心力衰竭患者进行重血管化,其中保留了喷射分数和冠状动脉疾病
Mingqiang Fu1, Yanyan Wang1, Xueting Han1
1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Institute of Cardiovascular Diseases, Shanghai, China; National Clinical Research Center for Interventional Medicine, Shanghai, China.
The American journal of cardiology
|January 10, 2024
概括
在患有冠状动脉疾病 (CAD) 和心力衰竭与保存喷射分数 (HFpEF) 的患者中,完整的再血管化显著减少了重复手术和心血管死亡. 这种方法可能会改善这个复杂的患者群体的结果.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
背景情况:
- 冠状动脉疾病 (CAD) 是心力衰竭的主要原因之一,心力衰竭具有保存的射出分数 (HFpEF).
- 在患有CAD的HFpEF患者中,重血管化的有效性尚未得到充分证实.
研究的目的:
- 评估完整与不完整/不复血管化的对诊断为HFpEF和CAD的患者临床结果的影响.
主要方法:
- 在2017年1月至2019年12月期间,对1,111名被诊断为HFpEF和CAD的患者进行了回顾性分析.
- 患者被分为完全重血管化 (n=780) 和不完全/没有重血管化 (n=331) 组.
- 结果包括无计划的再血管化,HF再入院和心血管死亡在355天的中位随访期间被跟踪.
主要成果:
- 与不完整/不进行血管再循环相比,完全血管再循环的无计划重复血管再循环率 (4.7%对10.9%) 和心血管死亡率 (0.1%对0.9%) 显著降低.
- 两组之间没有观察到HF再入院,中风或胃肠道出血的显著差异.
- 超脂血症,先前的心肌梗塞,静脉支架静止症和重血管化方法与复合不良事件有关.
结论:
- 完整的再血管化似乎可以降低HFpEF和CAD患者意外重复手术和心血管死亡的风险.
- 进一步的研究可能是有必要的,以优化这个特定的患者群体的重血管化策略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K


